Nanalysis

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

Retrieved on: 
Thursday, April 4, 2024
Nuclear magnetic resonance, Prohibition, Culture, NSCI, Substance abuse, MRI, Artificiality, NRC, AB, NMR, Research, FRA, Plasma protein binding, LKA, AI, NPS, Laboratory, Nanalysis, OTCQX, National Research Council, Artificial intelligence, Medical imaging

This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide.

Key Points: 
  • This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide.
  • In many cases these laboratories face significant sample backlog due to volume and may have difficulties in identifying new designer drugs.
  • These tools will not only identify known illicit drugs but will also identify unknown drugs that are derivatives of known illicit substances also referred to as designer drugs or new psychoactive substances (NPS).
  • The company is developing this application in the context of its quantitative NMR platform technology, which has other applications as well, beyond illicit drug detection.

Nanalysis Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 29, 2023
EBITDA, Party, Pressure, Research, The Company, NMR, Sime, Security, CATSA, FRA, NSCI, AB, Marketing, QUAD, Airport, Mumbai High Field, Security Service, Growth, MRI, Partial return reverse swap, Government, Cryptocurrency, Video game, Clothing, Q2, Nanalysis, Q3, Countertop

CALGARY, AB, Nov. 29, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023.

Key Points: 
  • CALGARY, AB, Nov. 29, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023.
  • "We had a good third quarter with continued strength in Security Services and we are encouraged by the results we are seeing in Benchtop Sales NMR with a 61% improvement sequentially over Q2, 2023," said Sean Krakiwsky Founder and CEO of Nanalysis.
  • Gross profit margins on product sales were 43% for the three months ended September 30, 2023.
  • There was continued training for the CATSA project that began in the first quarter of 2023, resulting in net training expenses of $689K for the three months ending September 30, 2023, and $2,580K for the nine months ending September 30, 2023 .

Nanalysis Reports Second Quarter 2023 Results

Retrieved on: 
Thursday, August 24, 2023
NSCI, Interim, CATSA, NMR, Airport, AB, G&A, Research, FRA, Sale, Government, Security, Security Service, ATB Financial, MRI, Quad, OTCQX, The Company, Consolidated, Party, Video game, Airline, Cryptocurrency, Nanalysis, Worldwide

CALGARY, AB, Aug. 24, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its second quarter results ending June 30, 2023.

Key Points: 
  • CALGARY, AB, Aug. 24, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its second quarter results ending June 30, 2023.
  • "Our topline results of $6,956k in sales is encouraging on a sequential and year over year basis," said Sean Krakiwsky Founder and CEO of Nanalysis.
  • 3rd Party Equipment: Second quarter sales grew 52% over Q1 2023, though still trailed behind Q2 2022 sales.
  • This represents costs related to anticipated headcount reductions that will take place over the rest of 2023, primarily during the third quarter.

Nanalysis Enters into New Credit Facility with ATB Financial

Retrieved on: 
Friday, June 30, 2023
NSCI, Borrowing base, TSX Venture Exchange, ATB Financial, NMR, Credit agreements in South Africa, AB, Primary Dealer Credit Facility, Research, FRA, The Company, MRI, OTCQX, Warrant, Growth, ATB, Letter, Credit, Security (finance), Nanalysis

Furthermore, with ATB Financial's approval, the Company could obtain up to an additional $5 million incremental term loan.

Key Points: 
  • Furthermore, with ATB Financial's approval, the Company could obtain up to an additional $5 million incremental term loan.
  • The new Credit Facilities are expected to provide improved financial flexibility to help the Company manage its operations, implementation of contracts, and future growth.
  • The Credit Facilities will be secured by, inter alia, a general security agreement over the property of Nanalysis and certain of its subsidiaries.
  • In connection with the Credit Agreement, the Company has granted 500,000 common share purchase warrants to ATB Financial (the "Warrants").

Nanalysis to Present at LD Micro Invitational XIII

Retrieved on: 
Wednesday, May 31, 2023
OTCQX, NSCI, MRI, AB, Nanalysis, Research, FRA, NMR, Rare-earth element, Cryptocurrency, Management

The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings.

Key Points: 
  • The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 meetings.
  • Nanalysis is scheduled to present on Tuesday, June 6, at 1:30 pm PT.
  • Sean Krakiwsky, Nanalysis CEO will be leading the presentation.
  • We invite interested parties to register to watch the presentation virtually here or by using this link: https://ldinv13.sequireevents.com/

Nanalysis Reports First Quarter 2023 Results

Retrieved on: 
Thursday, May 25, 2023
NSCI, CATSA, Completeness, NMR, Bank statement, Airport, AB, Research, FRA, Government, Security, Security Service, ATB Financial, MRI, Quad, OTCQX, The Company, Cryptocurrency, Airline, Nanalysis, Q3

CALGARY, AB, May 25, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its first quarter results ending March 31, 2023.

Key Points: 
  • CALGARY, AB, May 25, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its first quarter results ending March 31, 2023.
  • Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results.
  • "Nanalysis reported consolidated revenue of $4,674K for the first quarter of 2023," said Sean Krakiwsky Founder and CEO of Nanalysis.
  • Medical: RS2D began work on a large pre-clinical MRI project during the first quarter but has not yet reached the project milestones required under IFRS to allow for revenue recognition in Q1 2023.

Nanalysis Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
Thursday, April 27, 2023
Canada, NSCI, Workforce, Canadian Air Transport Security Authority, CATSA, Q&A, Face, NMR, Airport, AB, Business, Aviation, Research, ENC, FRA, Security, High-field domain, Security Service, MRI, Acquisition, Investment, Quad, Economic development, OTCQX, The Company, Management, Growth, Conference, Cryptocurrency, Airline, Nanalysis

CALGARY, AB, April 27, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its fourth quarter and full year results ending December 31, 2022.

Key Points: 
  • CALGARY, AB, April 27, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its fourth quarter and full year results ending December 31, 2022.
  • Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results.
  • "This past year was pivotal for Nanalysis on our path to becoming a fully vertically integrated scientific instrumentation company," said Sean Krakiwsky, Founder and CEO of Nanalysis.
  • And finally, we continue to see the MRI portion of our business progress with two million dollar plus wins in 2022."

Nanalysis Scientific Corp. Announces $3.5 Million Private Placement

Retrieved on: 
Friday, April 21, 2023
NSCI, Unit, Minority, CATSA, Nanalysis, Indian stock exchange, TSX Venture Exchange, MI, NMR, AB, FRA, MRI, Offering, OTCQX, Multilateral, Security (finance)

‎

Key Points: 
  • ‎
    Nanalysis CEO and Founder Sean Krakiwsky states, "As we enter into the final stages of rolling out the $160 million CATSA Airport service contract, we wanted to be prudent and bolster our balance sheet.
  • As I've stated publicly before, we are building a fully vertically integrated scientific instrumentation company.
  • This vision includes a scaled-up service organization, and the CATSA contract accelerates that aspect of our vision.
  • I want to thank the many of our long term shareholders and stakeholders for stepping up and making this happen."

Nanalysis and QUAD Systems Launch Full 400MHz High Field System

Retrieved on: 
Tuesday, April 18, 2023
NSCI, Nanalysis, NMR, AB, Convention center, ENC, FRA, High-field domain, MRI, OTCQX, The Company, Research, Conference, QUAD, Medical imaging

Nanalysis collaborated and provides the console as one of the key components for this new system.

Key Points: 
  • Nanalysis collaborated and provides the console as one of the key components for this new system.
  • "This product line enables QUAD Systems to expand and move up market into the High Field NMR space.
  • With our product innovations, we aim to provide our customers in the field of high-resolution NMR spectroscopy a suitable system solution."
  • For more information regarding ENC 2023 visit: https://www.enc-conference.org/Conference-2023 , under Nanalysis or Quad Systems.

Nanalysis Announces Appointment of Randall McRae as CFO

Retrieved on: 
Tuesday, February 28, 2023
NMR, Randall, NSCI, Partner, OTCQX, MNP LLP, Entrepreneurship, MRI, Automation, MNP, University of Calgary, Growth, CPA, CFO, FRA, AB, Commerce, Nanalysis

CALGARY, AB, Feb. 28, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1 ), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces the appointment of Randall McRae to Chief Financial Officer.

Key Points: 
  • CALGARY, AB, Feb. 28, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1 ), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces the appointment of Randall McRae to Chief Financial Officer.
  • "Randall has done an outstanding job since stepping into the interim role over seven months ago," said Sean Krakiwsky, Founder and CEO of Nanalysis.
  • As one of two founding partners, Randall helped grow McRally LLP from inception to over 100 active clients.
  • Randall is a member of the Institute of Chartered Professional Accountants of Alberta and holds a Bachelor of Commerce degree from the University of Calgary.